114 related articles for article (PubMed ID: 1445620)
1. Mutational analysis of a dominant oncogene (c-Ki-ras-2) and a tumor suppressor gene (p53) in hamster lung tumorigenesis.
Oreffo VI; Lin HW; Gumerlock PH; Kraegel SA; Witschi H
Mol Carcinog; 1992; 6(3):199-202. PubMed ID: 1445620
[TBL] [Abstract][Full Text] [Related]
2. K-ras and p53 point mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced hamster lung tumors.
Oreffo VI; Lin HW; Padmanabhan R; Witschi H
Carcinogenesis; 1993 Mar; 14(3):451-5. PubMed ID: 8453721
[TBL] [Abstract][Full Text] [Related]
3. K-ras mutations in lung tumors from A/J and A/J x TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate.
Matzinger SA; Crist KA; Stoner GD; Anderson MW; Pereira MA; Steele VE; Kelloff GJ; Lubet RA; You M
Carcinogenesis; 1995 Oct; 16(10):2487-92. PubMed ID: 7586156
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors.
Chen B; Liu L; Castonguay A; Maronpot RR; Anderson MW; You M
Carcinogenesis; 1993 Aug; 14(8):1603-8. PubMed ID: 8353844
[TBL] [Abstract][Full Text] [Related]
5. Comparison of pulmonary O6-methylguanine DNA adduct levels and Ki-ras activation in lung tumors from resistant and susceptible mouse strains.
Devereux TR; Belinsky SA; Maronpot RR; White CM; Hegi ME; Patel AC; Foley JF; Greenwell A; Anderson MW
Mol Carcinog; 1993; 8(3):177-85. PubMed ID: 8216736
[TBL] [Abstract][Full Text] [Related]
6. Ki-ras mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-initiated and butylated hydroxytoluene-promoted lung tumors in A/J mice.
Matzinger SA; Gunning WT; You M; Castonguay A
Mol Carcinog; 1994 Sep; 11(1):42-8. PubMed ID: 7916989
[TBL] [Abstract][Full Text] [Related]
7. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
[TBL] [Abstract][Full Text] [Related]
8. Alterations in the K-ras and p53 genes in rat lung tumors.
Belinsky SA; Swafford DS; Finch GL; Mitchell CE; Kelly G; Hahn FF; Anderson MW; Nikula KJ
Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):901-6. PubMed ID: 9255578
[TBL] [Abstract][Full Text] [Related]
9. p53 and Ha-ras mutations in chemically induced hamster buccal pouch carcinomas.
Chang KW; Lin SC; Koos S; Pather K; Solt D
Carcinogenesis; 1996 Mar; 17(3):595-600. PubMed ID: 8631150
[TBL] [Abstract][Full Text] [Related]
10. Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners.
Vähäkangas KH; Samet JM; Metcalf RA; Welsh JA; Bennett WP; Lane DP; Harris CC
Lancet; 1992 Mar; 339(8793):576-80. PubMed ID: 1347094
[TBL] [Abstract][Full Text] [Related]
11. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
12. Increased c-Ki-ras expression in hamster lung exposed to N-nitrosodiethylamine and hyperoxia as detected by the polymerase chain reaction.
Ning H; Oreffo VI; Gumerlock PH; Witschi H
Cancer Lett; 1991 Jul; 59(1):75-80. PubMed ID: 1715235
[TBL] [Abstract][Full Text] [Related]
13. Characterization and mapping of DNA damage induced by reactive metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) at nucleotide resolution in human genomic DNA.
Cloutier JF; Drouin R; Weinfeld M; O'Connor TR; Castonguay A
J Mol Biol; 2001 Oct; 313(3):539-57. PubMed ID: 11676538
[TBL] [Abstract][Full Text] [Related]
14. Assessment of mutations of Ha- and Ki-ras oncogenes and the p53 suppressor gene in seven malignant mesothelioma patients exposed to asbestos--PCR-SSCP and sequencing analyses of paraffin-embedded primary tumors.
Kitamura F; Araki S; Tanigawa T; Miura H; Akabane H; Iwasaki R
Ind Health; 1998 Jan; 36(1):52-6. PubMed ID: 9473858
[TBL] [Abstract][Full Text] [Related]
15. Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma.
Rall CJ; Yan YX; Graeme-Cook F; Beauchamp R; Yandell DW; Povoski SP; Rustgi AK
Pancreas; 1996 Jan; 12(1):10-7. PubMed ID: 8927612
[TBL] [Abstract][Full Text] [Related]
16. Ras oncogene and p53 gene hotspot mutations in colorectal cancers.
Lin SY; Chen PH; Yang MJ; Chen TC; Chang CP; Chang JG
J Gastroenterol Hepatol; 1995; 10(2):119-24. PubMed ID: 7787154
[TBL] [Abstract][Full Text] [Related]
17. G --> A mutation of ras genes and infrequent p53 gene mutation in rat transplantable thyroid carcinoma lines from tumors induced in vivo by N-bis(2-hydroxypropyl)nitrosamine.
Kitahori Y; Naitoh H; Konishi N; Fukushima M; Ohnishi T; Hiasa Y
Cancer Lett; 1996 Feb; 100(1-2):55-62. PubMed ID: 8620454
[TBL] [Abstract][Full Text] [Related]
18. Frequent mutations of Ki-ras but no mutations of Ha-ras and p53 in lung lesions induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
Kitada H; Tsutsumi M; Tsujiuchi T; Takahama M; Fukuda T; Narita N; Konsihi Y
Mol Carcinog; 1996 Apr; 15(4):276-83. PubMed ID: 8634086
[TBL] [Abstract][Full Text] [Related]
19. Multiple genetic alterations in hamster pancreatic ductal adenocarcinomas.
Chang KW; Laconi S; Mangold KA; Hubchak S; Scarpelli DG
Cancer Res; 1995 Jun; 55(12):2560-8. PubMed ID: 7780969
[TBL] [Abstract][Full Text] [Related]
20. G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents.
Ronai ZA; Gradia S; Peterson LA; Hecht SS
Carcinogenesis; 1993 Nov; 14(11):2419-22. PubMed ID: 7902220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
